Literature DB >> 11792878

Rheumatoid Arthritis Severity Scale: a brief, physician-completed scale not confounded by patient self-report of psychological functioning.

W A Bardwell1, P M Nicassio, M H Weisman, R Gevirtz, D Bazzo.   

Abstract

OBJECTIVE: The purpose of this study was to develop a brief measure of severity for rheumatoid arthritis (RA) that would not be seriously confounded by psychological functioning. The Rheumatoid Arthritis Severity Scale (RASS), designed for use by physicians on their own patients, consists of three visual analogue scales: Disease Activity, Functional Impairment and Physical Damage.
METHODS: Ninety-four RA outpatients completed the Health Assessment Questionnaire (HAQ) Disability, Pain Severity, Health State subscales and the Symptom Checklist-90-Revised (SCL-90-R) Anxiety, Depression and Somatization subscales. Rheumatologists completed the RASS on their own patients.
RESULTS: Results suggest that the RASS is internally consistent (alpha=0.85) and valid. RASS Disease Activity, Functional Impairment, Physical Damage correlated with HAQ Disability (r=0.40, 0.68, 0.61; P<0.01), Pain (r=0.37, 0.34, 0.34; P<0.01) and Health State (r=-0.27, -0.36, -0.27; P<0.01). RASS Physical Damage uniquely predicted longer illness duration (years with RA). In contrast to the HAQ, RASS subscales shared less variance with anxiety, somatization and depression scores.
CONCLUSIONS: Preliminary data suggest that the RASS may be a quick, reliable, valid physician-completed RA severity scale that compares favourably with the longer, patient-completed HAQ.

Entities:  

Mesh:

Year:  2002        PMID: 11792878     DOI: 10.1093/rheumatology/41.1.38

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  10 in total

1.  Patient-physician discordance in assessments of global disease severity in rheumatoid arthritis.

Authors:  Jennifer L Barton; John Imboden; Jonathan Graf; David Glidden; Edward H Yelin; Dean Schillinger
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-06       Impact factor: 4.794

2.  Augmentation of Physician Assessments with Multi-Omics Enhances Predictability of Drug Response: A Case Study of Major Depressive Disorder.

Authors:  Arjun Athreya; Ravishankar Iyer; Drew Neavin; Liewei Wang; Richard Weinshilboum; Rima Kaddurah-Daouk; John Rush; Mark Frye; William Bobo
Journal:  IEEE Comput Intell Mag       Date:  2018-07-20       Impact factor: 11.356

Review 3.  Comparative effectiveness research with administrative health data in rheumatoid arthritis.

Authors:  Marie Hudson; Koray Tascilar; Samy Suissa
Journal:  Nat Rev Rheumatol       Date:  2016-04-15       Impact factor: 20.543

4.  Physical Activity and Correlates of Physical Activity Participation Over Three Years in Adults With Rheumatoid Arthritis.

Authors:  Maura D Iversen; Michelle Frits; Johan von Heideken; Jing Cui; Michael Weinblatt; Nancy A Shadick
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-08-25       Impact factor: 4.794

5.  Effectiveness and Costs of TNF-Alpha Blocker Use for Patients with Rheumatoid Arthritis.

Authors:  Kavita Nair; Vahram Ghushchyan; Ahmad Naim
Journal:  Am Health Drug Benefits       Date:  2013-03

Review 6.  Targeting Medication Non-Adherence Behavior in Selected Autoimmune Diseases: A Systematic Approach to Digital Health Program Development.

Authors:  Trevor van Mierlo; Rachel Fournier; Michael Ingham
Journal:  PLoS One       Date:  2015-06-24       Impact factor: 3.240

7.  Will 14-3-3η Be a New Diagnostic and Prognostic Biomarker in Rheumatoid Arthritis? A Prospective Study of Its Utility in Early Diagnosis and Response to Treatment.

Authors:  Doaa Shawky Alashkar; Radwa Mostafa Elkhouly; Amira Yousef Abd Elnaby; Doaa Waseem Nada
Journal:  Autoimmune Dis       Date:  2022-01-04

8.  Treatment with TNF-α inhibitors versus methotrexate and the association with dementia and Alzheimer's disease.

Authors:  David M Kern; Simon Lovestone; M Soledad Cepeda
Journal:  Alzheimers Dement (N Y)       Date:  2021-09-20

9.  The validity of a rheumatoid arthritis medical records-based index of severity compared with the DAS28.

Authors:  Masayo Sato; Sebastian Schneeweiss; Richard Scranton; Jeffrey N Katz; Michael E Weinblatt; Jerry Avorn; Gladys Ting; Nancy A Shadick; Daniel H Solomon
Journal:  Arthritis Res Ther       Date:  2006-03-14       Impact factor: 5.156

10.  Tele-health interventions to support self-management in adults with rheumatoid arthritis: a systematic review.

Authors:  Alison MacIver; Hannah Hollinger; Clare Carolan
Journal:  Rheumatol Int       Date:  2021-06-16       Impact factor: 2.631

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.